Multiple myeloma
Top Cited Papers
- 22 June 2009
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 374 (9686), 324-339
- https://doi.org/10.1016/s0140-6736(09)60221-x
Abstract
No abstract availableThis publication has 138 references indexed in Scilit:
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- Preclinical Studies of Novel Targeted TherapiesHematology/Oncology Clinics of North America, 2007
- From the bench to the bedside: emerging new treatments in multiple myelomaBest Practice & Research Clinical Haematology, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Vasculogenic mimicry by bone marrow macrophages in patients with multiple myelomaOncogene, 2007
- Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation to Treat Patients with Poor-Risk, Relapsed, or Refractory Multiple MyelomaTransplantation and Cellular Therapy, 2007
- Bone marrow mesenchymal stem cells are abnormal in multiple myelomaLeukemia, 2007
- Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trialThe Lancet, 2006
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998